Revamping the Indian Pharma Supply Chain: A Comprehensive Report

The report recommends upskilling and digitizing pharmacies to enhance their role in the supply chain.

August 28, 2024

102

Table of Contents

Last Updated on September 6, 2024 by The Health Master

Supply Chain

Supply Chain: The Indian pharmaceutical industry has witnessed a remarkable transformation over the past decade.

This evolution has been significantly accelerated by the COVID-19 pandemic and the implementation of stringent regulations like the Good Manufacturing Practices (Revised Schedule M) and Good Marketing Practices (UCPMP).

In response to these dynamic changes, Pharmarack Technologies, in partnership with the Indian Pharmaceutical Alliance (IPA), has released a comprehensive report titled “Changing Dynamics of Indian Pharma Supply Chain.”

Follow us on WhtasApp Channel

Key Findings from the Report

Compliance is Key: The report underscores the importance of compliance throughout the entire pharmaceutical supply chain, beginning with the doctor’s prescription.
Data-Driven Insights: The research methodology employed a multi-phase approach, leveraging Pharmarack’s advanced analytics platform to collect and analyze real-time data from over 200,000 chemists and 12,000 distributors.
Qualitative Perspectives: In-depth interviews with key stakeholders, including pharmaceutical companies, distributors, retail chemists, and industry experts, provided valuable qualitative insights.
Global Best Practices: The report also examines global best practices and identifies areas where India can learn from more developed markets.

Recommendations for a Robust Supply Chain

Empowering Pharmacies: The report recommends upskilling and digitizing pharmacies to enhance their role in the supply chain.
Prioritizing Patient Safety: Strengthening drug quality compliance is crucial to ensuring patient safety.
Combating Counterfeit Drugs: Enhancing transparency and traceability can help combat the issue of counterfeit drugs.
Leveraging Digital Technology: Building supply chain resilience requires the adoption of digital technologies for efficient operations.

Conclusion

The “Changing Dynamics of Indian Pharma Supply Chain” report offers valuable insights into the evolving landscape of the pharmaceutical industry.

“By implementing the recommended strategies, India can establish a more efficient, transparent, and resilient supply chain that ultimately benefits patients.”

“As Dhruv Gulati, CEO of Pharmarack Technologies, emphasized, “Patient welfare is the cornerstone of the pharma sector.”

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.